⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S3 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target

Ana Vujovic Laura de Rooij Ava Keyvani Chahi He Tian Chen Brian A. Yee Sampath K. Loganathan Lina Liu Derek C.H. Chan Amanda Tajik Emily Tsao Steven Moreira Pratik Joshi Joshua Xu Nicholas Wong Zaldy Balde Soheil Jahangiri Sasan Zandi Stefan Aigner John E. Dick Mark D. Minden Daniel Schramek G Yeo Kristin J. Hope

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplemental Figure S3 shows the generation of the bcCML mouse model and the effects of ELAVL1 on normal bone marrow in vivo.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vujovic et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522f1a https://doi.org/10.1158/2643-3230.27024908.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
2Supplementary Figure S4 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
3Supplementary Figure S4 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
4Supplementary Figure S2 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
5Supplementary Figure S2 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024

More related papers

Supplementary Figure S6 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
Supplementary Figure S6 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024
Supplementary Figure S5 from In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target2024